Log In
Print
BCIQ
Print
Print this Print this
 

MSB0010718C

Also known as: Anti-PD-L1

  Manage Alerts
Collapse Summary General Information
Company Merck KGaA
DescriptionHuman IgG1 mAb against programmed cell death 1 ligand 1 (PD-L1; B7-H1; CD274)
Molecular Target Programmed cell death 1 ligand 1 (PD-L1) (B7-H1) (CD274)
Mechanism of Action 
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today